mTOR activity is essential for retinal pigment epithelium regeneration in zebrafish
Open Access
- 10 March 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 18 (3) , e1009628
Abstract
The retinal pigment epithelium (RPE) plays numerous critical roles in maintaining vision and this is underscored by the prevalence of degenerative blinding diseases like age-related macular degeneration (AMD), in which visual impairment is caused by progressive loss of RPE cells. In contrast to mammals, zebrafish possess the ability to intrinsically regenerate a functional RPE layer after severe injury. The molecular underpinnings of this regenerative process remain largely unknown yet hold tremendous potential for developing treatment strategies to stimulate endogenous regeneration in the human eye. In this study, we demonstrate that the mTOR pathway is activated in RPE cells post-genetic ablation. Pharmacological and genetic inhibition of mTOR activity impaired RPE regeneration, while mTOR activation enhanced RPE recovery post-injury, demonstrating that mTOR activity is essential for RPE regeneration in zebrafish. RNA-seq of RPE isolated from mTOR-inhibited larvae identified a number of genes and pathways dependent on mTOR activity at early and late stages of regeneration; amongst these were components of the immune system, which is emerging as a key regulator of regenerative responses across various tissue and model systems. Our results identify crosstalk between macrophages/microglia and the RPE, wherein mTOR activity is required for recruitment of macrophages/microglia to the RPE injury site. Macrophages/microglia then reinforce mTOR activity in regenerating RPE cells. Interestingly, the function of macrophages/microglia in maintaining mTOR activity in the RPE appeared to be inflammation-independent. Taken together, these data identify mTOR activity as a key regulator of RPE regeneration and link the mTOR pathway to immune responses in facilitating RPE regeneration.Keywords
All Related Versions
Funding Information
- National Institutes of Health (R01-EY29410)
- National Institutes of Health (P30-EY08098)
- University of Pittsburgh Medical Center Immune Transplant and Therapy Center
- University of Pittsburgh Medical Center Immune Transplant and Therapy Center
- Research to Prevent Blindness
- Xiangya Medical School, Central South University
- China Scholar Council
This publication has 106 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Embryonic stem cell trials for macular degeneration: a preliminary reportThe Lancet, 2012
- Haploinsufficiency of Target of Rapamycin Attenuates Cardiomyopathies in Adult ZebrafishCirculation Research, 2011
- mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in miceJournal of Clinical Investigation, 2011
- Sodium Iodate Selectively Injuries the Posterior Pole of the Retina in a Dose-Dependent Manner: Morphological and Electrophysiological StudyNeurochemical Research, 2010
- Plzf Regulates Germline Progenitor Self-Renewal by Opposing mTORC1Cell, 2010
- PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosisExperimental Eye Research, 2010
- Promoting Axon Regeneration in the Adult CNS by Modulation of the PTEN/mTOR PathwayScience, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001